Novartis Buys Cancer Diagnosis Specialist Genoptix For $470 Million

25.01.2011 - Swiss drugmaker Novartis is strengthening its personalized medicine and cancer portfolio with the $470 million buy of U.S. cancer diagnostics company Genoptix. The deal, which...